Double-Blind study to assess the efficacy and safety of Olumacostat Glasaretil Gel versus vehicle gel when applied twice daily for 12 weeks in subjects with Acne Vulgaris on the face.
Qualified Participants Must:
Have active acne vulgaris on the face
Be at least 9 years of age
Have a total of at least 40 lesions on the face
Be willing to refrain from using any treatments for acne vulgaris, other than the investigational product
Qualified Participants May Receive:
Complimentary study medication and appropriate physician related care